中山醫學大學 |
2011 |
S100A4調控傳導路徑對於口腔黏膜下纖維化致病機轉之研究
|
蔡崇弘 |
中山醫學大學 |
2011 |
S100A4調控傳導路徑對於口腔黏膜下纖維化致病機轉之研究
|
蔡崇弘 |
中山醫學大學 |
2011-08-01 |
S100A4調控傳導路徑對於口腔黏膜下纖維化致病機轉之研究
|
蔡崇弘 |
中國醫藥大學 |
2014-06 |
S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS
|
(Yu-Jen Jou);花俊宏(Chun-Hung Hua);林嘉德(Chia-Der Lin);賴志河(Chih-Ho Lai);(Su-Hua Huang);蔡銘修(Ming-Hsui Tsai);(Jung-Yie Kao)*;林振文(Lin Cheng Wen)* |
亞洲大學 |
2014-05 |
S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS.
|
Jou, YJ;Jou, YJ;Hua, CH;Hua, CH;Lin, CD;Lin, CD;Lai, CH;Lai, CH;黃素華;Huang, Su-Hua;Tsai, MH;Tsai, MH;Kao, JY;Kao, JY;林振文 |
中國醫藥大學 |
2007-11-16 |
S100A8 Is Identified a Biomarker in HPV18 Infected Oral Squamous Cell Carcinomas by Suppression Subtraction Hybridization, Clinical Proteomics Analysis, and Immunohistochemistry Staining
|
羅婉瑜(Wan-Yu Lo); 賴建成(Chien-Chin Lai); 花俊宏(Chun-Hung Hua); 蔡銘修(Ming-Hsui Tsai); 黃宣(Shiuan-Yi Huang); 蔡長海(Chang-Hai Tsai); 蔡輔仁(Fuu-Jen Tsai)* |
亞洲大學 |
2007-06 |
S100A8 is identified as a biomarker of HPV18 infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis and immunohistochemistry staining
|
Lo, Wan-Yu;Chien-Chen Lai;Chun-Hung Hua;Tsai,Ming-Hsui;Shiuan-Yi Huang;Chang-Hai Tsai;Tsai,Fuu-Jen |
中國醫藥大學 |
2007-06 |
S100A8 is identified as a biomarker of HPV18 infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis and immunohistochemistry staining
|
羅婉瑜(Lo, Wan-Yu); 賴建成; 花俊宏(Chun-Hung Hua); 蔡銘修(Tsai,Ming-Hsui); 黃宣(Shiuan-Yi Huang); 蔡長海; 蔡輔仁(Tsai,Fuu-Jen)* |
中國醫藥大學 |
2007-06 |
S100A8 is identified as a biomarker of HPV18 infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis and immunohistochemistry staining
|
羅婉瑜(Lo, Wan-Yu); 賴建成(Chien-Chen Lai); 花俊宏(Chun-Hung Hua); 蔡銘修(Ming-Hsui Tsai); 黃宣?(Shiuan-Yi Huang); 蔡長海(Chang-Hai Tsai); 蔡輔仁(Fuu-Jen Tsai)* |
臺大學術典藏 |
2022-04-25T03:57:08Z |
S100a8/a9 enhances immunomodulatory and tissue-repairing properties of human amniotic mesenchymal stem cells in myocardial ischemia-reperfusion injury
|
Chen T.-J;Yeh Y.-T;Peng F.-S;Li A.-H;Wu S.-C.; Chen T.-J; Yeh Y.-T; Peng F.-S; Li A.-H; Wu S.-C.; SHINN-CHIH WU |
國立成功大學 |
2015-07 |
S100A9, AN EARLY ORAL CANCER RECURRENCE MARKER, EXERTS A PRO-TUMOUR EFFECT THROUGH MYELOID CELL RECRUITMENT AND IL-6 PRODUCTION
|
Wu, L. -W.; Fang, W. -Y.; Chen, Y. -W.; Hsiao, J. -R.; Liu, C. -S.; Chang, K. -C.; Kuo, Y. -Z.; Tsai, S. -T. |
臺北醫學大學 |
2018 |
S100B, NSE & TSPO AS A BIOMARKER FOR DIAGNOSIS OF ISCHEMIC STROKE
|
Mayuri Tuwar; 馬嶼 |
高雄醫學大學 |
2015 |
S100B與其交互作用蛋白STAMP2在糖尿病腎病變的角色
|
莊詔棠; Chuang, Chao-Tang |
高雄醫學大學 |
2009 |
S100B蛋白質在糖尿病腎病變中的角色
|
莊詔棠; Chuang, Chao-Tang |
臺大學術典藏 |
2021-05-21T11:40:23Z |
S100P as a marker for poor survival and advanced stage in gallbladder carcinoma
|
Mathai, Alka Mary; Alexander, Jacob; Huang, Hsuan Ying; Li, Chien Feng; YUNG-MING JENG; Fung, Kar Ming; Harris, William P.; Swanson, Paul E.; Truong, Camtu; Yeh, Matthew M. |
臺大學術典藏 |
2022-02-14T07:10:50Z |
S100P as a marker for poor survival and advanced stage in gallbladder carcinoma
|
Mathai A.M.; Alexander J.; Huang H.-Y.; Li C.-F.; YUNG-MING JENG; Fung K.-M.; Harris W.P.; Swanson P.E.; Truong C.; Yeh M.M. |
國立臺灣大學 |
2013 |
S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors
|
Yuan, Ray-Hwang; Chang, Ko-Tung; Chen, Yu-Ling; Hsu, Hey-Chi; Lee, Po-Huang; Lai, Po-Lin; Jeng, Yung-Ming; 許輝吉; 鄭永銘; 袁瑞晃; 賴寶蓮; 李伯皇 |
臺大學術典藏 |
2018-09-10T09:39:13Z |
S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors
|
Yuan, R.-H. and Chang, K.-T. and Chen, Y.-L. and Hsu, H.-C. and Lee, P.-H. and Lai, P.-L. and Jeng, Y.-M.; PO-HUANG LEE; RAY-HWANG YUAN; YUNG-MING JENG |
臺大學術典藏 |
2020-03-06T08:25:09Z |
S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors
|
Yuan R.-H.; Chang K.-T.; Chen Y.-L.; Hsu H.-C.; Lee P.-H.; Lai P.-L.; YUNG-MING JENG |
臺大學術典藏 |
2020-11-19T03:19:30Z |
S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors
|
Yuan R.-H.; Chang K.-T.; Chen Y.-L.; Hsu H.-C.; PO-HUANG LEE; Lai P.-L.; Jeng Y.-M. |
臺大學術典藏 |
2018-09-10T09:13:35Z |
S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas
|
Tsai, J.-H. and Huang, W.-C. and Kuo, K.-T. and Yuan, R.-H. and Chen, Y.-L. and Jeng, Y.-M.; RAY-HWANG YUAN; YUNG-MING JENG; KUAN-TING KUO |
臺大學術典藏 |
2020-03-06T08:25:13Z |
S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas
|
YUNG-MING JENG; Tsai J.-H.; Huang W.-C.; Kuo K.-T.; Yuan R.-H.; Chen Y.-L. |
臺大學術典藏 |
2012 |
S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas
|
Tsai J.-H.; Huang W.-C.; KUAN-TING KUO; Yuan R.-H.; Chen Y.-L.; Jeng Y.-M. |
臺大學術典藏 |
2020-03-05T07:31:50Z |
S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas
|
JIA-HUEI TSAI; Huang W.-C.; Kuo K.-T.; Yuan R.-H.; Chen Y.-L.; Jeng Y.-M. |
臺大學術典藏 |
2020-03-05T07:52:37Z |
S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas
|
Chen Y.-L.; Jeng Y.-M.; Tsai J.-H.; Huang W.-C.; KUAN-TING KUO; Yuan R.-H. |